Compare ASMB & USCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ASMB | USCB |
|---|---|---|
| Founded | 2005 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 442.9M | 368.2M |
| IPO Year | 2010 | 2021 |
| Metric | ASMB | USCB |
|---|---|---|
| Price | $26.75 | $20.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $44.20 | $23.00 |
| AVG Volume (30 Days) | ★ 245.6K | 58.2K |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.72% |
| EPS Growth | ★ 91.78 | 7.26 |
| EPS | N/A | ★ 0.51 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $26.46 |
| Revenue Next Year | $638.39 | $9.67 |
| P/E Ratio | ★ N/A | $39.67 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.90 | $16.06 |
| 52 Week High | $39.71 | $20.93 |
| Indicator | ASMB | USCB |
|---|---|---|
| Relative Strength Index (RSI) | 50.41 | 57.51 |
| Support Level | $26.18 | $17.65 |
| Resistance Level | $30.68 | $20.86 |
| Average True Range (ATR) | 1.46 | 0.56 |
| MACD | 0.01 | -0.06 |
| Stochastic Oscillator | 46.08 | 60.42 |
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.
USCB Financial Holdings Inc is a bank holding company. Through its banking subsidiary, it offers relationship-based banking products, services, and solutions to a diverse set of clients in the local markets it operates in and international clients with U.S. banking needs. The Group's products and services offerings mainly include traditional deposit products, including commercial and consumer checking accounts, money market deposit accounts, savings accounts, etc.; e-banking services; title insurance policies for real estate transactions; and a variety of lending products such as small business loans, commercial real estate loans, business credit cards, etc.; and others. Geographically, its primary banking market is South Florida.